Cancer Flashcards

1
Q

Cancer

A

large group of disorders with different causes, manifestations, treatments, and prognoses.
Most cancers occur in older adults.
78% of all cancer diagnoses are in people > 65 years. Incidence of overall cancer rate is higher in men than in women.
Second leading cause of death in the United States.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

benign tumors / benign neoplasms

A

does not spread, can become malignant in some cases

  • Margins of tumor are well defined
  • Cell growth is local
  • Cells are well-differentiated
  • Relatively innocuous, doesn’t metastasize
  • Slow rate of growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

malignant

A

has the potential to spread to other parts of the body.

  • Margins are poorly defined
  • Crab like appearance, hence the term cancer
  • are invasive
  • Neoplastic cells extend into and destroy surrounding tissue
  • Cells are not well-differentiated
  • Growth is erratic, slow to rapid
  • Can metastasize
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cancer incidence

A

Men: prostate, lung, colorectal Women: breast, lung, colorectal
Overall cancer rate deaths has declined.
- However, cancer death rates in African-American men remain substantially higher than those among Caucasian men and twice those of Hispanic men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Characteristics of Normal Cells

A
  • Have limited cell division
  • Undergo apoptosis
  • Show specific morphology
  • Have a small nuclear-cytoplasmic ratio
  • Perform specific differentiated functions
  • Adhere tightly together
  • Non-migratory
  • Grow in an orderly and well-regulated manner
  • Contact inhibited
  • Euploid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cancer pathophysiology

A
  • Cancer is a disease process that begins when a cell is transformed by genetic mutations of the cellular DNA.
  • Genetic mutations may be inherited and/or acquired, leading to abnormal cell behavior.
  • The initial genetically altered cell forms a clone and begins to proliferate abnormally, evading growth-regulating signals as well as the immune system defense mechanisms of the body.
  • Cells acquire a variety of capabilities that allow them to invade surrounding tissues and/or gain access to lymph and blood vessels, which carry the cells to other areas of the body (metastasis).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Characteristics of Cancer Cells

A
  • Have rapid or continuous cell division
  • Do not respond to signals for apoptosis
  • Show anaplastic morphology
  • Have a large nuclear-cytoplasmic ratio
  • Lose some or all differentiated functions
  • Adhere loosely together
  • Able to migrate through embryonic cells
  • Grow by invasion
  • Are euploid(when a human cell has an extra set of 23 chromosomes) with 23 pairs of chromosomes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cancer development

A

Initiation - occurs in genetic level, permits malignant transformation, DNA chain break, gene mutation activate proto-oncogenes
Promotion - cancer cell form tumor, promoting of agent beyond latency
Progression - cells show capacity to invade or metasize to surrounding tissues, tumor develops own blood supply, angiogenesis happen, TAF also happens
Metastasis - movement of cancer cell from primary to remote site, cells lose adherence property.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

carcinogenesis

A

malignant transformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Risk factors for cancer

A
  • Viruses and bacteria
  • Physical agents
  • Chemicals
  • Genetic or familial factors
  • Lifestyle factors
  • Hormones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cancer viruses

A

Accounts for about 15% of worldwide cancer cases

  • Retroviruses- t cell leukemia
  • Papillomavirus- cervical cancer
  • HIV-associated with Kaposi’s sarcoma
  • Herpes virus- Epstein-Barr virus, Burkitt’s lymphoma
  • Chronic hepatitis B- liver cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

viruses and bacteria etiology

A

Viruses are thought to incorporate themselves in the genetic structure of cells, thus altering future generations of that cell population (perhaps leading to cancer).
Physical Agents:
Exposure to sunlight or radiation, chronic irritation or inflammation, tobacco carcinogens, industrial chemicals, and asbestos.

Chemical Agents:
Tobacco, chewing tobacco, and passive smoking.
Pesticides and formaldehydes; arsenic, soot, and tars; asbestos; wood dust; etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

genetics and familial factors

A

Almost every cancer type has been shown to run in families.

May be due to genetics, shared environments, cultural or lifestyle factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Lifestyle factors for cancer

A
  • Diet, obesity, and insufficient physical activity.
  • Dietary substances that appear to increase the risk of cancer include fats, alcohol, salt-cured or smoked meats, nitrate- and nitrite- containing foods, and red and processed meats.
  • Alcohol intake should be limited to no more than two drinks per day for men and one drink per day for women.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

hormonal agents

A
  • Tumor growth may be promoted by disturbances in hormonal balance, either by the body’s own (endogenous) hormone production or by administration of exogenous hormones.
  • Cancers of the breast, prostate, and uterus are thought to depend on endogenous hormonal levels for growth.
  • Hormonal changes related to the female reproductive cycle are also associated with cancer incidence:
  • Early onset of menses (before age 12)
  • Delayed onset of menopause (after age 55)
  • Nulliparity
  • Delayed childbirth (after age 30)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

detection and prevention of cancer (primary prevention)

A

Concerned with reducing the risks of disease through health promotion and risk reduction strategies.

Programs may focus on the hazards of tobacco use, nutrition, and lifestyle changes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

detection and prevention of cancer (secondary prevention)

A

Involves screening and early detection activities that seek to identify early stage cancer in individuals who lack signs and symptoms suggestive of cancer.

Goal is to decrease cancer morbidity and mortality.

Mammograms, Digital Rectal Examinations (DRE), and PSA blood tests.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

detection and prevention of cancer (third prevention)

A

Focuses on monitoring for and preventing recurrence of the primary cancer as well as screening for development of second malignancies in cancer survivors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Proliferative Patterns

A
  • Hyperplasia- increase in the number of cells
  • Metaplasia- conversion of one type of mature cell into another type of cell
  • Dysplasia- bizarre cell growth
  • Anaplasia- lack normal cell characteristics, shape, and organization
  • Neoplasia- uncontrolled cell growth that follows no physiologic demand
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Carcinoma

A

tissue of origin: epithelial
-glandular or -squamous

characteristics: Accounts for 80% - 90% of all cancers
- Organs or glands capable of secretion.
- Covers or lines all external and internal body surfaces.

term: adenocarcinoma or squamous cell carcinoma

examples:

  • Adenocarcinoma of breast, lung, prostate
  • Squamous cell cancer of the skin, lung, esophagus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

sarcoma

A
tissue of origin: 
Connective or Supportive
-Bone
-Cartilage
-Adipose
-Smooth muscle
-Skeletal muscle
-Fibrous tissues
-Membranes lining body cavities
-Blood vessels
characteristics: Cancer of bone
Rare, from within bones
Deep soft tissue
Very rare
Most common in young
Long or flat bones
Related to asbestos exposure
Related to occupational exposure to vinyl chloride monomer
term:
Osteosarcoma
Chondro-sarcoma
Liposarcoma
Leiomyo-sarcoma
Rhabdo-sarcoma
Fibrosarcoma
Mesothelioma
Angiosarcoma
examples: 
Femur, humerus
Femur, pelvis
Retroperitoneum, thigh
Uterus, intestines, stomach
Head and neck, limbs
Femur, tibia, mandible
Pleura or peritoneum
Liver, heart
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Myeloma

A

tissue of origin: plasma cells
characteristics: Produced by B-cell lymphocytes; plasma cells produce antibodies.
Term: N/A
Example: N/A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Lymphoma

A
Tissue of origin: Lymphocytes
Characteristics:Two main classifications; may involve lymph nodes and/or  body organs.
Term:
-Non-Hodgkin lymphoma
-Hodgkin lymphoma
Example: 
-B-cell lymphoma
-T-cell lymphoma
-N/A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Leukemia

A
Tissue of origin:
Hematopoietic cells in the bone marrow
-White blood cells
-Lymphocytes
-Red blood cells
Characteristics: 
Involves various cell lines produced in the bone marrow
N/A
N/A
Involves overproduction of RBCs and is associated with increased levels of WBCs and platelets; also risk of additional bone marrow disease
Term:
Myelogenous

Lymphocytic

Erythremia

Examples:
Acute myelogenous leukemia
Acute lymphocytic leukemia
Polycythemia vera

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Diagnosis of Cancer

A

Patients with suspected cancer undergo extensive testing to:
Determine the presence and extent of cancer,

Identify possible spread (metastasis) of disease or invasion of other body tissues,

Evaluate the function of involved and uninvolved body systems and organs,

Obtain tissue and cells for analysis, including evaluation of tumor stage and grade.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Nurses’ role in patient diagnosis of cancer

A

The nurse can help relieve fears and anxiety by explaining the:

tests to be performed

sensations likely to be experienced

patient’s role in the test procedures

During this time of diagnosis with cancer, the Nurse:

Encourages the patient and family to voice their fears about the test results

Supports the patient and family throughout the test period

Reinforces and clarifies information conveyed by the physician

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Tumor Staging & Grading

A

Determines the size of the tumor, the existence of local invasion, lymph node involvement, and distant metastasis.

“TNM” system is frequently used.
“T” refers to the extent of the primary tumor.
“N” refers to lymph node involvement.
“M” refers to the extent of metastasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Stage vs Grade

A

Grade=histologic estimate of the degree of differentiation of a tumor
Determined by a pathologist
Looks for differentiation
Stage=clinical extent of size and spread of tumor
Determined clinically
Size of primary lesion and presence or absence of metastases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Grading

A

-Grade I Tumors:
Well-differentiated tumors
Closely resemble the tissue of origin in structure and function.

-Grade IV Tumors:
Poorly differentiated or undifferentiated.
Do not clearly resemble the tissue of origin in structure or function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Modes of spread

A

Local invasion

  • by most direct route or lines of least resistance such as naturally occurring tissue planes
  • —-Around nerve bundles, favored by prostatic cancers

Lymphatic spread
-Typical of carcinomas, especially breast cancer

Seeding
- local seeding, surgery

Vascular spread

  • Favored path of sarcomas
  • Arteries less penetrated than veins

Angiogenesis

  • Malignant cells have ability to induce growth of new capillaries from host tissue to meet needs for nutrients and oxygen.
  • Vascular network can allow tumor emboli to enter systemic circulation and travel to distant sites.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Cancer classification

A

Solid Tumors- associated with organs from which they develop.

Hematological cancers- originate from blood cell-forming tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Types of cancer

A
-By location
Skin – squamous cell carcinoma
Glands – adenocarcinoma
Bone – osteosarcoma, Ewing’s sarcoma
Brain – gliomas, astrocytoma, neuroblastoma
Lung, breast, liver, pancreas,etc 
-Hematologic (cells, vessels)
Leukemia, myeloma, lymphoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Role of the immune system in cancer

A
  • Detects development of malignant cells
  • Destroys malignant cells before they become uncontrolled
  • T-lymphs – type of white blood cell, part of immune system, fight infection and may fight cancer
  • Macrophages – defends, may favor tumor
  • B-lymphs- makes antibodies
  • NKs (natural killers) produce enzymes that assist in cell destruction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Signs and Symptoms : Caution

A
C- change in bowel or bladder habits
A- a sore that does not heal
U- unusual bleeding or discharge
T- thickening or lump in breast or elsewhere
 I- indigestion or difficulty swallowing
O- obvious change in wart or mole
N- nagging cough or hoarseness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Cancer screening

A
  • Pap smears – start 21, 21-29 every 3 yrs, 30-65 every 5 yrs
  • Breast self exam –monthly
  • Mammograms-40-44, 45-54 every yr, 55 every 2 yrs, HX of breast cancer 25yr older
  • Stool for occult blood - prn
  • Colonoscopy – after 50yrs, every 10 yrs
  • Chest x-ray - prn
  • Prostate exams – 50yrs
  • Testicular self exam – monthly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Diagnostics

A
Symptomology
-Takes a lot of cell growth before s/s noted
-s/s dependent on location and size
-X-ray, CT, MRI, Bone Scans
-Biopsy
-Labs
      Tumor marker identification
      Genetic markers (Brca-1,2 
      for breast CA)
      PSA (Prostate CA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Leukemia

A

Malignant # of immature leukocytes – sudden or chronic onset
S/S– bleeding, anorexia, fatigue, wt loss
Nursing – isolation, bleeding precautions (avoid IM Injections, avoid invasive procedures), monitor VS, temp, WBC, avoid raw fruits, vegs, plants, pepper, pad side rails, electric razors, count pads (menstruating)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Hodgkin’s

A

Malignancy of lymph nodes that spreads
S/S– fever, fatigue, night sweats, enlarged lymph nodes, anorexia, wt loss
Nursing – monitor for s/s of chemo, radiation, monitor for s/s infection and bleeding, discuss possible sterility for male pt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Multiple Myeloma

A

Malignant amount of plasma cells and tumors within the bones
S/S– bone pain (esp. pelvis, spine), fatigue, recurrent infections, osteoporosis
Nursing – careful handling of pt in bed, monitor for s/s bleeding, fractures, force fluids, observe for s/s renal failure (too much calcium released from bone – clogs kidneys), pain control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Testicular

A

Most often between 15-40 yrs
Metathesis to lung, liver, bone, adrenals
S/S– painless, testicular swelling, dragging sensation in scrotum, back or bone pain,
Nursing – prepare for chemo, surgery, possible sterility, discuss sperm options (Sperm Banking)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Cervical, Ovarian, Endometrial

A

Involves cervix and other pelvic structures
S/S – painless vaginal bleeding, pelvic pain, vag. discharge, leakage of urine & feces from vag., dysuria, hematuria, enlarged uterus, abd. Swelling.
Nursing – prepare for laser, cryo (watery discharge for several wks), conization, hysterectomy, or pelvic exenteration procedures (colostomy, ileal conduit)

42
Q

Breast

A

Usually noted when mass felt in breast – spreads easily via lymph
S/S – fixed, irregular, non-encapsulated usually painless mass until late stages, nipple discharge, dimpling (peau d’orange skin), swollen lymph nodes in axilla
Nursing – elevate affected arm, no sticks, BP in arm, diuretics for lymphedema, Reach for Recovery

43
Q

GI

A

Malignant masses or polyps that lead to obstruction, abscess formation, and bleeding
S/S – anorexia, wt. loss, N/V, indigestion, dysphagia, ascites, blood in stools, change in stools/pattern
Nursing – monitor labs (CBC), prepare for surgery (NPO, NG Tube (do not irrigate or remove without order), observe for s/s obstruction, prepare for colostomy, ileostomy

44
Q

Lung

A

May be primary or metastatic sites(Brain, lymph nodes, bones, liver, spine, adrenal gland).
S/S – cough, dyspnea, hemoptysis, chest pain, anorexia, wt loss, weakness
Nursing – semi-fowlers, assess breath/lung sounds & effort, prepare for surgery, chest tubes, oxygen, pulse ox,

45
Q

Urological

A

Prostate – slow growing, men over 50 yrs
S/S– asymptomatic in early stages, pea sized nodule on rectal exam, hematuria, urinary obstruction, pain down leg
Bladder – growth from bladder wall spreads to pelvic structures, mets to lungs
Nursing – TURP or prostatectomy, CBI, meds for spasms, monitor for blood loss, push fluids, prepare for ileal conduit, Kock pouch, self caths, monitor I&O, s/s UTI

46
Q

Kubler – RossStages of Grieving

A
Denial and isolation
Anger
Bargaining
Depression
Acceptance
47
Q

Management of Cancer

A

The range of possible treatment goals may include:
Cure
complete eradication of malignant disease

Control
prolonged survival and containment of cancer cell growth

Palliation
relief of symptoms associated with the disease and improvement of quality of life

Surgery
Radiation therapy
Chemotherapy
Hematopoietic stem cell transplantation(Bone Marrow)
Hyperthermia 
Targeted therapies
Combination of all and any type
Unconventional therapy
48
Q

Chemotherapy

A

In chemotherapy, antineoplastic agents are used in an attempt to destroy tumor cells by interfering with cellular functions including replication and DNA repair.

Chemotherapy is used primarily to treat systemic disease rather than localized lesions that are amenable to surgery or radiation.

Chemotherapy may be combined with surgery, radiation therapy, or both, to:
reduce tumor size preoperatively, to destroy any remaining tumor cells postoperatively, or to treat some forms of leukemia or lymphoma.

49
Q

Chemotherapy: Safe Handling

A

Puncture, and leak-proof containers, IV bags

Needleless systems

Surgical N-95 respirator (respiratory & splash protection)

Double layer of gloves (inner glove worn under gown cuff, outer glove worn over cuff)

Long sleeve, disposable gowns

Closed-system, puncture- and leak-proof containers labeled “hazardous: chemotherapy contaminated” for linens.

Wash hands

50
Q

Chemo drugs

A

Goal: destroy tumor cells, (cure, control, palliation)
Drugs usually used in combination – to combat cell resistance
Cancer trials – testing of new drugs -ethics
Length of therapy depends on multiple factors; cellular response, pt’s tolerance
Side effects depend on length, amount, frequency, pt’s health status prior, nutrition

51
Q

Chemo drugs continuation

A

-Rarely given via peripheral IV due to vascular damage and possibility of extravasations
-Central lines
-Implanted ports
Very common, good for
years if taken care of,
requires special needle,
insertion technique

52
Q

Chemo drugs (side effects)

A
  • Alopecia
  • Nausea / vomiting / diarrhea
  • Loss of appetite
  • Weight loss
  • Stomatitis (now referred to as mucositis)
  • Increased risk for infection bone marrow suppression
  • Fluid and electrolyte imbalance
  • Bleeding disorders / anemias
  • Reproductive problems (ovulation, sterility)
  • Fatigue
  • Depression
  • Coping problems
  • Family disruption
53
Q

Infection

A

Leading cause of death in cancer patients.

Monitor lab studies to detect early changes in WBC counts.

Assess common sites of infection frequently:
pharynx, skin, perianal area, urinary tract, and respiratory tract.

Typical signs of infection (swelling, redness, drainage, and pain) may not occur in immunosuppressed patients.

Any temperature of 101°F or higher is reported and dealt with promptly.

Cultures are obtained.

Strict asepsis is essential!

Exposure of the patient to others with active infections and to crowds is avoided.

Patients may receive low-bacteria diets, avoiding fresh fruits and vegetables.

Invasive procedures are avoided.

54
Q

infection (continuation)

A

Gram-positive bacteria (Streptococcus and Staphylococcus species) and gram-negative organisms (Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa) are the most frequently isolated causes of infection.

Fungal organisms, such as Candida albicans, also contribute to the incidence of serious infection.

Viral infections are caused mostly by herpesviruses and respiratory viruses.

Fever is probably the most significant sign of infection in immunocompromised patients.

55
Q

Septic Shock

A

Septic shock is often associated with overwhelming gram-negative bacterial infections.

Nurse monitors blood pressure, pulse rate, respirations, and temperature every 15 to 30 minutes.

ABGs and pulse oximetry are monitored to determine tissue oxygenation.

Nurses administer IV fluids, blood products, and vasopressors as prescribed to maintain blood pressure and tissue perfusion.

Broad-spectrum antibiotics may be prescribed to combat the underlying infection.

56
Q

Bleeding & Hemorrhage

A

Assess the patient for factors that may contribute to bleeding:
-Bone marrow suppression from radiation, chemotherapy, and other medications that interfere with platelet functioning (i.e. aspirin, heparin, warfarin, etc.).

Common bleeding sites include:
-Skin and mucous membranes; the intestinal, urinary, and respiratory tracts; and the brain.

-Gross hemorrhage, as well as blood in the stools, urine, sputum or vomitus; oozing at infection sites; bruising; petechiae; and changes in mental status, are monitored and reported.

57
Q

Bleeding and Hemorrhage:

cont.

A

Bleeding and Hemorrhage:
Thrombocytopenia (most common cause of bleeding in patients with cancer) is defined as a platelet count of less than 100,000/mm3.
When platelet count decreases to between 20,000 – 50,000/mm3, the risk of bleeding increases.
Platelet counts lower than 20,000/mm3 are associated with an increased risk for spontaneous bleeding (requires a platelet transfusion).
Encourage patient to use a soft, not stiff, toothbrush and an electric, not straight-edged, razo

58
Q

bleeding and hemorrhage (nursing intervention)

A
  • Nurse avoids unnecessary invasive procedures (i.e. rectal temperatures, IM injections, catheterization).
  • Soft foods, increased fluid intake, and stool softeners.
  • Extremities are handled and moved gently to minimize the risk of spontaneous bleeding.
  • Monitor BP and pulse rates every 15 – 30 minutes.
  • Hemoglobin and hematocrit are monitored.
  • Nurse tests all urine, stool, and emesis for occult blood.
  • Nurse administers fluids and blood products as prescribed.
  • O2 may be needed
59
Q

Pain

A

Relieving Pain:
Although it is controllable, cancer pain is commonly irreversible and not quickly resolved.

Adequate rest and sleep, diversion, mood elevation, empathy, and medications such as antidepressants, antianxiety agents, and analgesics enhance tolerance to pain

60
Q

WHO advocates a three-step approach to treat cancer pain

A

Nonopioid analgesics (i.e. acetaminophen) = mild pain

Weak opioid analgesics (i.e. codeine) = moderate pain

Strong opioid analgesics (i.e. morphine) = severe pain

61
Q

pain assessment

A

Pain assessment scales are useful (FLACC for the nonverbal patient).

62
Q

Causes of pain

A
  • Bone destruction
  • Obstruction of an organ
  • Compression of peripheral nerves
  • Infiltration/distention of tissue
  • inflammation/necrosis of tissue
  • Psychological, such as fear and anxiety
63
Q

Pain Control

A

-Do not undermedicate a cancer patient!!
-Pain management program
-Start with mildest medications and increase as needed
-Monitor for side effects and effectiveness of meds
Also provide non-pharmacological methods

64
Q

Fatigue

A

Most commonly reported side effect in patients who receive chemotherapy and radiation therapy.

Patient may become less verbal and may appear pale, with relaxed facial musculature.

65
Q

Psychosocial Status:

A

Assess the patient’s mood and emotional reaction to the results of diagnostic testing and prognosis and looks for evidence that the patient is progressing through the stages of grief.

66
Q

Decreasing Fatigue:

A

Alternating periods of rest and activity are beneficial.

Regular, light exercise may decrease fatigue and facilitate coping.

Lack of physical activity and “too much rest” can actually contribute to deconditioning and associated fatigue.

67
Q

Cancer Emergencies

A

-Disseminated intravascular coagulation (DIC) is a rare, life-threatening condition. In the early stages of the condition, DIC causes your blood to clot excessively.
-Superior vena cava syndrome(SVCS), is a group of symptoms caused by obstruction of thesuperior vena cava(“SVC”), a short, wide vessel carrying circulating blood into the heart.
-Cardiac tamponadeoccurswhentheheartis
squeezedbyfluidthatcollectsinsidethesac
thatsurroundsit.
-Pleural effusions is excess fluid that accumulates in thepleural cavity, the fluid-filled space that surrounds thelungs. This excess fluid can impairbreathingby limiting the expansion of the lungs
-Spinal cord compression Spinal cord compression occurs when a mass places pressure on the cord. A mass can include a tumor or bone fragment.
-Tumor lysis syndrome * a positive sign of effective treatment but leads to ↑ K+, ↑ uricemia which leads to kidney failure

68
Q

Nurse’s Role

A

Know the basics about cancer - options
Know the common side effects of chemo and radiation therapy – that affect the patient and the nurse
Be aware of resources for your patients and their family members
If becoming an oncology nurse, take a chemo course

69
Q

Assessment

A
S/S: 
some symptoms may be vague and be present for awhile, others may start suddenly, depends on type of cancer
Knowledge: 
patient’s current level, past history, readiness, stage of grief
Financial resources: 
helps to make choices
Family support: 
previous coping, availability
70
Q

Nursing Diagnosis

A
Knowledge deficit
Pain
Immobility / Self Care deficit
Safety
Nutrition / Fluid & electrolyte balance
Body image
Coping / Anxiety
71
Q

Goals or Outcomes

A
Maintain nutritional balance
Limit, reduce pain
Accept diagnosis, prognosis
Understand disease process
Understand treatments
Live with dignity
72
Q

Nursing Interventions

A

Involve pt and family in planning care
Teach, teach, teach, explain….. meds, tx,
Provide time, privacy, family interactions
Provide resource, support group information
Protect patient (immunosuppression)
Follow protocols for chemo, radiation, etc.
Skin and mouth care
Monitor lab results – CBC, bleeding times
Nutritional support
Pain management
IV site care
Infection control / Isolation requirements
Assessment of systems for changes

73
Q

Special Problems: Extravasation

A

Special care must be taken whenever intravenous vesicant agents are administered.

Vesicants are those agents that, if deposited into the subcutaneous tissue (extravasation), cause tissue necrosis and damage to underlying tendons, nerves, and blood vessels.

Sloughing and ulceration of tissue may be so severe that skin grafting may be necessary.

If extravasation is suspected, the medication administration is stopped immediately, and ice is applied to the site.

74
Q

Antineoplastic drugs

A

Antineoplastic drugs are often mutagenic, teratogenic, and carcinogenic. In addition, direct contact with the skin, eyes, and mucous membranes can result in local injury (and can increase cancer risk if enough drug is absorbed).

75
Q

Handling Cytotoxic Drug

A

To minimize the risk of injury, IV administration should be performed only into a vein with good flow. Sites of previous irradiation should be avoided. If extravasation occurs, the infusion should be discontinued immediately

76
Q

Vesicants

A
a class of drugs that causes tissue necrosis if deposited into subq tissue  (adriamycin, nitrogen mustard, vincristine)
To minimize the risk of injury, IV administration should be performed only into a vein with good flow. Sites of previous irradiation should be avoided. If extravasation occurs, the infusion should be discontinued immediately
77
Q

Extravasation

A

ulceration – total extent of necrosis not known immediately, may involve tendons, muscles, bone

78
Q

What if your patient is receiving chemo?

A

Careful monitoring of IV site (periph and central)
Stop infusion immed. If s/s extrav., occur - redness, pain, swelling, inability to obtain blood return, sluggish flow of fluid
Apply ice, (unless vinca alkaloid,(vincristine) and notify physician
Have neutralizing agent (Na Bicarb is one) available for specific chemo drug

79
Q

General nursing interventions

for chemo drugs

A

Monitor for side effects of drug
Monitor labs **CBC, uric acid, electrolytes
Contact physician for any untoward problems
Encourage hydration and nutrition
Administer other meds such as Benadryl, Zyloprim (Allopurinol) (to reduce serum uric acid)
Follow safety guidelines when preparing meds monitor IV sites frequently

80
Q

Targeted Therapy

A

Targeted therapies seek to minimize the negative effects on healthy tissues by disrupting:

specific cancer cell functions such as malignant transformation,

communication pathways,

processes for growth and metastasis,

genetic coding.

Mechanisms of action of targeted therapies include:

  • stimulation or augmentation of immune responses through the use of biologic response modifiers
  • targeting of cancer cell growth factors
  • promotion of apoptosis (programmed cell death)
  • genetic manipulation through gene therapy
81
Q

Surgery

A

Surgery as Primary Treatment:

Goal is to remove

  • Entire tumor or as much as is feasible
  • Procedure sometimes called debulking

Any involved surrounding tissue, including regional lymph nodes
Local Excision:
- Mass is small

  • Outpatient basis
  • Removal of mass and small margin of normal tissue that is easily accessible.

Wide or Radical Excision:
- Removal of the primary tumor, lymph nodes, adjacent involved structures, and surrounding tissues that may be at higher risk for tumor spread.

  • Considered if the tumor can be removed completely and the chances of cure or control are good.

Prophylactic or Risk Reduction Surgery:
Involves removing non-vital tissues or organs that are at increased risk of developing cancer.

The following factors are considered when discussing possible prophylactic surgery:
Family history and genetic predisposition; presence or absence of signs and symptoms; potential risks and benefits; ability to detect cancer at an early stage; alternative options for managing increased risk; patient’s acceptance of postoperative outcomes.

Colectomy, mastectomy, and oophorectomy are examples.

82
Q

Diagnostic Surgery (biopsy):

A

Usually performed to obtain a tissue sample for analysis of cells suspected to be malignant.

Biopsy is taken from the actual tumor, but in some situations, it is necessary to biopsy lymph nodes near the suspicious tumor.

83
Q

Palliative Surgery:

A

When surgical cure is not possible, goals are to relieve symptoms, make the patient as comfortable as possible, and promote quality of life.

Performed in an attempt to relieve symptoms, such as ulceration, obstruction, hemorrhage, pain, and malignant effusions.

84
Q

Reconstructive Surgery:

A

May follow curative or extensive surgery in an attempt to improve function or obtain a more desirable cosmetic effect.
Performed in one operation or in stages.

85
Q

Radiation Therapy

A

Approximately 60% of patients receive radiation at some point.

Radiation may be used:
To cure the cancer (i.e. thyroid carcinomas, localized cancers of the head and neck, and cancers of the cervix)

To control malignant disease when a tumor cannot be removed surgically or when local nodal metastasis is present

Prophylactically to prevent local recurrence or spread of microscopic cells

Palliative radiation therapy is used to relieve the symptoms of metastatic disease or to treat oncologic emergencies.

Goal of therapy – reduce size of tumor
Types of therapy: internal & external
Common side effects of radiation
Skin irritations, n/v, weakness, depends on which body part/organ involved
Destroys cancer cells with minimal damage to surrounding tissue by rads
Nursing implications r/t radiation therapy

86
Q

Radiation Therapy (internal and external )

A

Internal: placement of “seeds” of radiation into body cavities or directly into certain organs (brachytherapy).
Protocols for nursing care involve time in contact with the patient, distance between pt and nurse r/t time in room

External: scheduled times to go to x-ray department & scheduled length of visits.

87
Q

Brachytherapy

A

Seeds in direct contact with tumor cells
Pt emits radiation during therapy (time varies) and is a danger to others
Rads are eliminated via excreta – so pt is dangerous for up to 48 hrs
Limit time of exposure to staff (< 30 mins), wear protective lead shield, no pregnant nurses, no children, limit visitors
No sex for about 10 days post therapy

88
Q

Biologic Therapy

A
Recognized as the 4th cancer treatment
Modify the relationship between the host and the tumor by altering the biologic response of the tumor cells.
Hematopoieic growth factors (HGFs)
   Colony-stimulating factors (CSFs) 
   Erythropoietin (EPO) 
   Interferons, Interleukins
89
Q

Bone Marrow transplants

A

Used for treatment of cancer patients who initially respond to therapy then have a reoccurence.
Types of transplants
Allogeneic: marrow from a sibling or parent
Syngeneic: marrow from an identical twin
Autologous: marrow from the patient; harvested during remission, stored frozen & infused later **most common type

Harvested by aspirations from iliac crest
Given back to pt via IV central line (like blood) either IV push or over 30 mins
Pt in danger of infection for up to 5 wks until marrow engrafts

90
Q

Graft Verus Host Disease (GVHD)

A

Graft Verus Host Disease (GVHD) - the grafted cells are trying to attack the host cells = an unfortunate complication

If marrow fails to engraft – death will follow unless another transplant is done and is successful

91
Q

Complications of Cancer

A

GI system: n/v, diarrhea, anorexia, stomatitis
Hematopoetic system: bone marrow suppression, anemias
Renal system: fluid & electrolyte imbalance due to increased demand on filtration and excretion of cell lysis products (esp. K++, calcium)
Cardio-pulmonary system: CHF, cardiac ejection fraction changes, pulmonary fibrosis
Reproductive system: sterility
Pain
Neurologic system: neuropathy

92
Q

Care of the Oncology Patient

A
As a result of the underlying disease or various treatment modalities, patients with cancer may experience secondary problems such as:
Reduced WBC counts
Infection
Bleeding
Skin problems
Nutritional problems
Pain 
Fatigue
Psychological stress
93
Q

Stomatitis

A

Stomatitis, refers to an inflammatory process of the mouth including the mucosa and tissues surrounding the teeth.

Characterized by:
Changes in sensation
Mild erythema
Edema

If severe:
Painful ulcerations
Bleeding
Secondary infection

Commonly develops 5 – 14 days after patients receive certain chemotherapeutic agents.

Tissues within mouth and gastrointestinal tract become ulcerated and susceptible to invasion, which can result in infection.

Severe oral pain can significantly affect swallowing, nutritional intake, speech, quality of life, coping abilities, and willingness to adhere to treatment regimens.

Maintenance of good oral hygiene is necessary to minimize the risk of oral complications associated with cancer therapies:
Brushing
Flossing
Rinsing
Dental care
94
Q

Palifermin (Kepivance),

A

Palifermin (Kepivance), an IV administered synthetic form of human keratinocyte growth factor promotes epithelial cell repair and accelerated replacement of cells in the mouth and gastrointestinal tract.

95
Q

Managing Stomatitis

A

Use soft-bristled toothbrushes and nonabrasive toothpaste.
for 90 seconds after meals and at bedtime.

Oral swabs with sponge-like applicators may be used in place of a toothbrush.

Flossing may be performed unless it causes pain or unless platelet levels are less than 40,000/mm3.

Oral rinses (saline solution or tap water) may be necessary for those who can’t tolerate tooth brushing (every 1 – 4 hours).

Products that irritate oral tissues or impair healing (i.e. alcohol-based mouth rinses) are avoided.

Avoid foods that are difficult to chew or are hot or spicy.

Lips are lubricated.

Adequate fluid and food intake is encouraged.

Parenteral hydration and nutrition may be necessary (depending on severity of stomatitis).

Remove dentures (only use them for eating)

96
Q

Radiation-Associated Skin Impairment

A

Avoid the use of soaps, cosmetics, perfumes, powders, lotions, and ointments; non-aluminum-based deodorant may be used on intact skin.

Use only lukewarm water to bathe the area.

Avoid rubbing or scratching area.

Avoid shaving the area with a straight-edged razor.

Avoid applying hot-water bottles, heating pads, ice, and adhesive tape to the area.

Avoid exposing the area to sunlight or cold weather.

Avoid tight clothing.
- Use cotton clothing.

Apply vitamin A and D ointment.

97
Q

Alopecia

A

Temporary or permanent thinning or complete loss of hair is a potential adverse effect of whole brain radiation therapy and various chemotherapeutic agents.
Usually begins 2 – 3 weeks after initiation of treatment.
Regrowth most often begins within 8 weeks after the last treatment.
For many patients, hair loss is a major assault on body image.
Hair loss can serve as a constant reminder of the challenges cancer places on their coping abilities, interpersonal relationships, and sexuality.
Assist patient in selecting and using cosmetics, scarves, hair pieces, hats, and clothing that increase his or her sense of attractiveness.
Patient is encouraged to acquire a wig or a hairpiece before hair loss occurs so that the replacement matches the patient’s own hair.

98
Q

Alopecia (cont)

A

Use of attractive scarves and hats may make the patient feel less conspicuous.

Knowledge that hair usually begins to regrow after therapy is completed may comfort some patients.
Color and texture of new hair may be different.

99
Q

Promoting Nutrition

A

Most patients with cancer experience some weight loss during their illness.

Common Nutritional Problems:
Anorexia, malabsorption, and cancer-related anorexia-cachexia syndrome (CACS).

Causes of anorexia in patients with cancer:
Alterations in taste, manifested by increased salty, sour, and metallic taste sensations, and altered responses to sweet and bitter flavors.

Anorexia may occur because patients develop early satiety after eating only a small amount of food.
Psychological distress throughout illness may also have a negative impact on appetite.
Patients may develop an aversion to food because of nausea and vomiting associated with treatment.
Chemotherapy and radiation associated with mucositis cause damage to mucosal cells of the bowel, resulting in impaired nutrient absorption

100
Q

Cancer-Related Anorexia-Cachexia Syndrome:

A
  • Continued weight loss and malnutrition characterized by loss of adipose tissue, visceral protein, and skeletal muscle mass.
  • Patient complains of loss of appetite, early satiety, and fatigue.
  • 50 – 75% of patients experience some degree cachexia.
101
Q

General Nutritional Considerations:

A

Food should be prepared in ways that make it appealing.
Small, frequent meals are provided, with supplements between meals
Patients often tolerate large amounts of food earlier in the day rather than later.
Patient should avoid drinking fluids while eating (to avoid early satiety).

Oral hygiene before mealtime often makes meals more pleasant.

If adequate nutrition can’t be maintained by oral intake, nutritional support via the enteral route (NG tube, gastrostomy, or jejunostomy) may be necessary.